Puma Cash And Short Term Investments from 2010 to 2026

PBYI Stock  USD 6.00  -0.14  -2.28%   
Analyzing Puma Biotechnology's Cash And Short Term Investments over time reveals patterns in financial health and operational efficiency. The Cash And Short Term Investments reference series shown here is based on Puma Biotechnology's publicly filed financial data. Puma Biotechnology's Cash And Short Term Investments are increasing over recent years with slightly volatile volatility. However, the most recent period shows a reversal: It is projected to decline toward approximately 80.7 M. Cash And Short Term Investments is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. Full Reported Financial Data
 
Cash And Short Term Investments  
 First Reported
2007-09-30
 Previous Quarter
94.4 M
 Current Value
97.5 M
 Quarterly Volatility
67.4 M
Macro event markers
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
The Cash And Short Term Investments trend for Puma Biotechnology offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Puma Biotechnology is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Puma Biotechnology's Cash And Short Term Investments Growth Pattern

Below is the plot of the Cash And Short Term Investments of Puma Biotechnology over the last few years. Short Term Investments is an account in the current assets section of Puma Biotechnology balance sheet. This account contains Puma Biotechnology investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Puma Biotechnology fairly quickly. It is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. Puma Biotechnology's Cash And Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Puma Biotechnology's overall financial position and show how it may be relating to other accounts over time.
Cash And Short Term Investments10 Years Trend
Slightly volatile
   Cash And Short Term Investments   
       Timeline  

Puma Cash And Short Term Investments Regression Statistics

Arithmetic Mean 86,715,127
Geometric Mean 66,450,109
Coefficient Of Variation 49.60
Mean Deviation 28,946,351
Median 83,948,000
Standard Deviation 43,012,451
Sample Variance1850.1T
Range193.1M
R-Value 0.27
Mean Square Error1830.9T
R-Squared 0.07
Significance 0.30
Slope 2,289,344
Total Sum of Squares29601.1T

Puma Cash And Short Term Investments History

202680.7 M
202597.5 M
2024101 M
202395.9 M
202281.1 M
202182.1 M
202093.4 M

Methodology, Assumptions & Data Sources

This page provides reference data for Puma Biotechnology's Cash And Short Term Investments, tracking historical values and trends over time. Cross-referencing with related fundamentals can improve interpretive accuracy.

Unless otherwise specified, data for Puma Biotechnology is compiled from periodic company reporting and market reference feeds and standardized for comparability. Analyst inputs may be included when coverage is available. Updates may occur throughout the day. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.

This content is curated and reviewed by:

Ellen Johnson - Member of Macroaxis Editorial Board
Last reviewed on February 25th, 2026